OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma

HTML PDF

Year: 2014
Type: article
Study design: Clinical Trial
Source: Blood
DOI: 10.1182/blood-2014-05-576256
Authors: Pieter Sonneveld, Emilie Asselbergs, Sonja Zweegman, Bronno van der Holt, Marie Jose Kersten, Edo Vellenga, Marinus van Marwijk-Kooy, Annemiek Broyl, Okke de Weerdt, Sarah Lonergan, Antonio Palumbo, Henk Lokhorst
Institutions: Erasmus MC, Amsterdam UMC Location Vrije Universiteit Amsterdam, Erasmus MC Cancer Institute, Amsterdam UMC Location University of Amsterdam, University Medical Center Groningen, Isala, St. Antonius Ziekenhuis, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, University of Turin, University Medical Center Utrecht
Language: English

Topic: Multiple Myeloma Research and Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: carfilzomib, thalidomide, dexamethasone, multiple myeloma, induction therapy, consolidation therapy, transplant-eligible patients, autologous stem cell transplantation, complete response, progression-free survival, adverse events, polyneuropathy
SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Onyx Pharmaceuticals
OpenAlex ID: W2120362266
FWCI: 5.494
Cites: 37
Cited by: 69
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security